Concepedia

Jilin Xing

JX

4

Publications

234

Citations

4

H-Index

2016

Active since

Affiliations

China Medical University(Current)

Jilin Xing is an author at China Medical University specializing in oncology, radiation oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2016–2019

4

Publications

4

SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway

Lin Fu, Qian Dong, Jiani He et al. · Oncogene · 2016 · 130 citations

, , +8

Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins

Xitao Chen, Xiaodi Sun, Jingqian Guan et al. · Cellular Physiology and Biochemistry · 2017 · 40 citations · Full text

SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway

Jilin Xing, Ji Li, Lin Fu et al. · Cancer Medicine · 2019 · 37 citations · Full text

Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549

Feifei Shen, Junda Gai, Jilin Xing et al. · Biochemical and Biophysical Research Communications · 2017 · 27 citations

, , +10

Rows per page

1–4 of 4